In 1994, Estella Matues proposed a scoring system for the diagnosis of CLL, “Matutes Scores" (MS), which initially included the evaluation of surface membrane immunoglobulin (SmIg) weak, CD5, CD19, CD23, CD22, and FMC7 [5]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.